Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71 | ||
| dc.conicet.organizacion | Xuzhou Medical College | |
| dc.conicet.organizacion | The General Hospital of The Chinese People | |
| dc.conicet.organizacion | Poten Biomedical Institute for Cancer Immunotherapy | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas | |
| dc.conicet.organizacion | Poten Biomedical Institute for Cancer Immunotherapy | |
| dc.conicet.organizacion | Poten Biomedical Institute for Cancer Immunotherapy | |
| dc.conicet.organizacion | Xi | |
| dc.conicet.organizacion | The General Hospital of The Chinese People | |
| dc.conicet.organizacion | Poten Biomedical Institute for Cancer Immunotherapy | |
| dc.contributor.author | Zhao, Fei | |
| dc.contributor.author | Wang, Han | |
| dc.contributor.author | Kunda, Patricia Elena | |
| dc.contributor.author | Chen, Xuemei | |
| dc.contributor.author | Liu, Qiu Ling | |
| dc.contributor.author | Liu, Tao | |
| dc.date.issued | 2013 | |
| dc.description.abstract | Retinoblastoma (RB) is an intraocular cancer that affects young children. There is an ongoing effort to find new agents for RB management that are effective, specific and with few side-effects. In the present study, we tested artesunate (ART), a synthetic derivative from the herbal drug artemisinin, used in the clinic for the treatment of malaria. We analyzed ART cytotoxicity in an RB cell line (RB-Y79) and in a retinal epithelial cell line (hTERT-RPE1) by flow cytometric analysis (FCM). We related the effect of ART to the expression of transferrin receptor 1 (TfR-1, also known as CD71) by knocking down CD71 with RNAi and analyzing cell cycle variables by FCM. We found that the cytotoxic action of ART is specific for RB cells in a dose-dependent manner, with low toxicity in normal retina cells. ART is more effective in RB than carboplatin with a markedly strong cytotoxic effect on carboplatin-resistant RB cells. RB had higher CD71 levels at the membrane compared to normal retinal cells. We showed that ART internalization in RB cells is dependent upon the expression of the CD71. In addition, ART blocked the cell cycle progression at the G1 phase, even at low doses, and decreased the proportion of RB cells in the S phase. In conclusion, we showed that ART is a promising drug exhibiting high selective cytotoxicity even against multidrug-resistant RB cells. Thus, we suggest that ART could be used in the treatment of RB. | es |
| dc.description.fil | Fil: Zhao, Fei. Xuzhou Medical College; China. The General Hospital of The Chinese People; China | |
| dc.description.fil | Fil: Wang, Han. Poten Biomedical Institute for Cancer Immunotherapy; China | |
| dc.description.fil | Fil: Kunda, Patricia Elena. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Poten Biomedical Institute for Cancer Immunotherapy; China | |
| dc.description.fil | Fil: Chen, Xuemei. Poten Biomedical Institute for Cancer Immunotherapy; China. Xi; China | |
| dc.description.fil | Fil: Liu, Qiu Ling. The General Hospital of The Chinese People; China | |
| dc.description.fil | Fil: Liu, Tao. Poten Biomedical Institute for Cancer Immunotherapy; China | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Zhao, Fei; Wang, Han; Kunda, Patricia Elena; Chen, Xuemei; Liu, Qiu Ling; et al.; Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71; Spandidos Publ Ltd; Oncology Reports; 30; -1-2013; 1473-1482 | es |
| dc.identifier.eissn | 1791-2431 | |
| dc.identifier.issn | 1021-335X | |
| dc.identifier.uri | http://hdl.handle.net/11336/11445 | |
| dc.journal.ciudad | Atenas | es |
| dc.journal.pagination | 1473-1482 | es |
| dc.journal.pais | Grecia | es |
| dc.journal.title | Oncology Reports | es |
| dc.journal.volume | 30 | es |
| dc.language.iso | eng | es |
| dc.publisher | Spandidos Publ Ltd | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3892/or.2013.2574 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.spandidos-publications.com/10.3892/or.2013.2574 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | es |
| dc.subject | Retinoblastoma | es |
| dc.subject | Artemisin | es |
| dc.subject | Transferrin Receptor | es |
| dc.subject | Carboplatin Resistant | es |
| dc.subject.classification | Otras Ciencias de la Salud | es |
| dc.subject.classification | Ciencias de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71 | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.14835.pdf
- Tamaño:
- 1.01 MB
- Formato:
- Adobe Portable Document Format